Page last updated: 2024-08-26

mafosfamide and Cancer, Second Primary

mafosfamide has been researched along with Cancer, Second Primary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdallah, A; Egerer, G; Haas, R; Ho, AD; Körbling, M; Weber-Nordt, RM	1

Trials

1 trial(s) available for mafosfamide and Cancer, Second Primary

Article	Year
Long-term outcome in acute myelogenous leukemia autografted with mafosfamide-purged marrow in a single institution: adverse events and incidence of secondary myelodysplasia. Bone marrow transplantation, 2002, Volume: 30, Issue:1 Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Female; Humans; Incidence; Leukemia, Myeloid, Acute; Longitudinal Studies; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prognosis; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation	2002

Article

Year

Long-term outcome in acute myelogenous leukemia autografted with mafosfamide-purged marrow in a single institution: adverse events and incidence of secondary myelodysplasia.

Bone marrow transplantation, 2002, Volume: 30, Issue:1

Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Female; Humans; Incidence; Leukemia, Myeloid, Acute; Longitudinal Studies; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prognosis; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation

2002